The Louisville, Ky.-based payer partially credits its 16 percent growth in Medicare Advantage memberships for its strong performance in the second quarter, according to the report. A Trump administration executive order to move more kidney care to patients' homes also bolstered Humana's stock value because it owns a minority stake in a home health company, according to the report.
Humana's positive financial performance this year is seen as a boon as the company braces for the ACA's health insurance tax to be reinstated in 2020 after a one-year hiatus. Humana expects the tax to cost it $1 billion next year, according to the report.
Read more here.